Tag: percent

A landmark clinical trial supported by the National Institutes of Health and published on June 15, 2026, in the Journal of the American Medical Association has found that adults with…

The list of conditions that GLP-1 receptor agonists appear to protect against keeps getting longer. These drugs — which include semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound), and the newly approved…